All Title Author
Keywords Abstract

PLOS ONE  2014 

Regenerative Therapeutic Potential of Adipose Stromal Cells in Early Stage Diabetic Retinopathy

DOI: 10.1371/journal.pone.0084671

Full-Text   Cite this paper   Add to My Lib


Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults. Early stage DR involves inflammation, vascular leakage, apoptosis of vascular cells and neurodegeneration. In this study, we hypothesized that cells derived from the stromal fraction of adipose tissue (ASC) could therapeutically rescue early stage DR features. Streptozotocin (STZ) induced diabetic athymic nude rats received single intravitreal injection of human ASC into one eye and saline into the other eye. Two months post onset of diabetes, administration of ASC significantly improved “b” wave amplitude (as measured by electroretinogram) within 1–3 weeks of injection compared to saline treated diabetic eyes. Subsequently, retinal histopathological evaluation revealed a significant decrease in vascular leakage and apoptotic cells around the retinal vessels in the diabetic eyes that received ASC compared to the eyes that received saline injection. In addition, molecular analyses have shown down-regulation in inflammatory gene expression in diabetic retina that received ASC compared to eyes that received saline. Interestingly, ASC were found to be localized near retinal vessels at higher densities than seen in age matched non-diabetic retina that received ASC. In vitro, ASC displayed sustained proliferation and decreased apoptosis under hyperglycemic stress. In addition, ASC in co-culture with retinal endothelial cells enhance endothelial survival and collaborate to form vascular networks. Taken together, our findings suggest that ASC are able to rescue the neural retina from hyperglycemia-induced degeneration, resulting in importantly improved visual function. Our pre-clinical studies support the translational development of adipose stem cell-based therapy for DR to address both retinal capillary and neurodegeneration.


[1]  Prevent Blindness America website. Available: Accessed 2013 December 3.
[2]  Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, et al. (2004) The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122: 552–563.
[3]  Kern TS, Tang J, Berkowitz BA (2010) Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis 16: 2121–2131.
[4]  Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586: 4401–4408.
[5]  Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52: 1156–1163.
[6]  Du Y, Tang J, Li G, Berti-Mattera L, Lee CA, et al. (2010) Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest Ophthalmol Vis Sci 51: 2158–2164.
[7]  Kern TS (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007: 95103.
[8]  Li G, Veenstra AA, Talahalli RR, Wang X, Gubitosi-Klug RA, et al. (2012) Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice. Diabetes 61: 3294–3303.
[9]  von Tell D, Armulik A, Betsholtz C (2006) Pericytes and vascular stability. Exp Cell Res 312: 623–629.
[10]  Antonetti D (2009) Eye vessels saved by rescuing their pericyte partners. Nat Med 15: 1248–1249.
[11]  Cai J, Kehoe O, Smith GM, Hykin P, Boulton ME (2008) The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophthalmol Vis Sci 49: 2163–2171.
[12]  Tremolada G, Del Turco C, Lattanzio R, Maestroni S, Maestroni A, et al. (2012) The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment. Exp Diabetes Res 2012: 728325.
[13]  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977–986.
[14]  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159–2167.
[15]  Caballero S, Sengupta N, Afzal A, Chang KH, Li Calzi S, et al. (2007) Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 56: 960–967.
[16]  Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, et al. (2002) Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 8: 1004–1010.
[17]  Rehman J (2011) Chipping away at the surface of the endothelial progenitor cell (EPC) mystery. J Mol Med (Berl) 89: 943–945.
[18]  Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, et al. (2008) A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102: 77–85.
[19]  Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211–228.
[20]  Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Saadatzadeh MR, et al. (2009) Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 104: 1410–1420.
[21]  Mendel TA, Clabough EB, Kao DS, Demidova-Rice TN, Durham JT, et al. (2013) Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS One 8: e65691.
[22]  Yang Z, Li K, Yan X, Dong F, Zhao C (2010) Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch Clin Exp Ophthalmol 248: 1415–1422.
[23]  Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS (2012) Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech 5: 444–456.
[24]  Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292–1298.
[25]  Rajashekhar G, Traktuev DO, Roell WC, Johnstone BH, Merfeld-Clauss S, et al. (2008) IFATS collection: Adipose stromal cell differentiation is reduced by endothelial cell contact and paracrine communication: role of canonical Wnt signaling. Stem Cells 26: 2674–2681.
[26]  Cai L, Johnstone BH, Cook TG, Liang Z, Traktuev D, et al. (2007) Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 25: 3234–3243.
[27]  Dhong ES, Hwang NH, Kim DW, Rajashekhar G, Johnstone BH, et al. (2012) Morphologic changes in photodamaged organotypic human skin culture after treatment of autologous adipose-derived stromal cells. J Craniofac Surg 23: 805–811.
[28]  Wei X, Du Z, Zhao L, Feng D, Wei G, et al. (2009) IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells 27: 478–488.
[29]  Lundquist O, Osterlin S (1994) Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol 232: 71–74.
[30]  Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, et al. (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15: 641–648.
[31]  Tersey SA, Nishiki Y, Templin AT, Cabrera SM, Stull ND, et al. (2012) Islet beta-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61: 818–827.
[32]  Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, et al. (2010) The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 120: 2156–2170.
[33]  Kern TS, Miller CM, Tang J, Du Y, Ball SL, et al. (2010) Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Mol Vis 16: 1629–1639.
[34]  Li Q, Verma A, Han PY, Nakagawa T, Johnson RJ, et al. (2010) Diabetic eNOS-knockout mice develop accelerated retinopathy. Invest Ophthalmol Vis Sci 51: 5240–5246.
[35]  Rajashekhar G, Loganath A, Roy AC, Chong SS, Wong YC (2005) Extracellular matrix-dependent regulation of angiogenin expression in human placenta. J Cell Biochem 96: 36–46.
[36]  Ukrohne TU, Westenskow PD, Kurihara T, Friedlander DF, Lehmann M, et al. (2012) Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl Med 1: 96–109.
[37]  Merfeld-Clauss S, Gollahalli N, March KL, Traktuev DO (2010) Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation. Tissue Eng Part A 16: 2953–2966.
[38]  Freeman WM, Bixler GV, Brucklacher RM, Lin CM, Patel KM, et al. (2010) A multistep validation process of biomarkers for preclinical drug development. Pharmacogenomics J 10: 385–395.
[39]  Trudeau K, Molina AJ, Guo W, Roy S (2010) High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am J Pathol 177: 447–455.
[40]  Al-Shabrawey M, Ahmad S, Megyerdi S, Othman A, Baban B, et al. (2012) Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy. Mol Vis 18: 1895–1906.
[41]  Maumus M, Peyrafitte JA, D'Angelo R, Fournier-Wirth C, Bouloumie A, et al. (2011) Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) 35: 1141–1153.
[42]  Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, et al. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301–313.
[43]  Yang YI, Kim HI, Choi MY, Son SH, Seo MJ, et al. (2010) Ex vivo organ culture of adipose tissue for in situ mobilization of adipose-derived stem cells and defining the stem cell niche. J Cell Physiol 224: 807–816.
[44]  Sorrell JM, Baber MA, Traktuev DO, March KL, Caplan AI (2011) The creation of an in vitro adipose tissue that contains a vascular-adipocyte complex. Biomaterials 32: 9667–9676.
[45]  Zhang Y, Daquinag AC, Amaya-Manzanares F, Sirin O, Tseng C, et al. (2012) Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Res 72: 5198–5208.
[46]  Amos PJ, Shang H, Bailey AM, Taylor A, Katz AJ, et al. (2008) IFATS collection: The role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells 26: 2682–2690.
[47]  Hong SJ, Traktuev DO, March KL (2010) Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant 15: 86–91.
[48]  Amos PJ, Mulvey CL, Seaman SA, Walpole J, Degen KE, et al. (2011) Hypoxic culture and in vivo inflammatory environments affect the assumption of pericyte characteristics by human adipose and bone marrow progenitor cells. Am J Physiol Cell Physiol 301: C1378–1388.
[49]  Zografou A, Papadopoulos O, Tsigris C, Kavantzas N, Michalopoulos E, et al. (2013) Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats. Ann Plast Surg 71: 225–232.
[50]  Nie C, Yang D, Xu J, Si Z, Jin X, et al. (2011) Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 20: 205–216.
[51]  Gariano RF, Gardner TW (2005) Retinal angiogenesis in development and disease. Nature 438: 960–966.
[52]  Wei X, Zhao L, Zhong J, Gu H, Feng D, et al. (2009) Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett 462: 76–79.
[53]  Wong VH, Vingrys AJ, Bui BV (2011) Glial and neuronal dysfunction in streptozotocin-induced diabetic rats. J Ocul Biol Dis Infor 4: 42–50.
[54]  Aung MH, Kim MK, Olson DE, Thule PM, Pardue MT (2013) Early visual deficits in streptozotocin-induced diabetic long evans rats. Invest Ophthalmol Vis Sci 54: 1370–1377.
[55]  Burch S, Bogaards A, Siewerdsen J, Moseley D, Yee A, et al. (2005) Photodynamic therapy for the treatment of metastatic lesions in bone: studies in rat and porcine models. J Biomed Opt 10: 034011.
[56]  Chen Y, Douglass T, Jeffes EW, Xu Q, Williams CC, et al. (2002) Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a “paraptosis”-induced pathway that promotes systemic immunity against intracranial T9 gliomas. Blood 100: 1373–1380.
[57]  Dauchy RT, Dauchy EM, Sauer LA, Blask DE, Davidson LK, et al. (2004) Differential inhibition of fatty acid transport in tissue-isolated steroid receptor negative human breast cancer xenografts perfused in situ with isomers of conjugated linoleic acid. Cancer Lett 209: 7–15.
[58]  Rose WC, Long BH, Fairchild CR, Lee FY, Kadow JF (2001) Preclinical pharmacology of BMS-275183, an orally active taxane. Clin Cancer Res 7: 2016–2021.
[59]  Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, et al. (2000) Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2: 306–314.
[60]  Cai L, Johnstone BH, Cook TG, Tan J, Fishbein MC, et al. (2009) IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 27: 230–237.
[61]  Bassi EJ, Moraes-Vieira PM, Moreira-Sa CS, Almeida DC, Vieira LM, et al. (2012) Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes 61: 2534–2545.
[62]  Festing MF, May D, Connors TA, Lovell D, Sparrow S (1978) An athymic nude mutation in the rat. Nature 274: 365–366.
[63]  Sarawar SR, Yang CP, Bell EB (1991) T-cell receptor-bearing cells from athymic nude rats respond to alloantigen in vitro but are defective in vivo. Immunology 73: 334–341.
[64]  Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, et al. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158: 147–152.
[65]  Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, et al. (2003) Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J 17: 76–78.
[66]  Park SS, Caballero S, Bauer G, Shibata B, Roth A, et al. (2012) Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 53: 986–994.
[67]  Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175–3182.
[68]  Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, et al. (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46: 4281–4287.
[69]  Dong N, Li X, Xiao L, Yu W, Wang B, et al. (2012) Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro. Invest Ophthalmol Vis Sci 53: 7567–7575.
[70]  Yuen TJ, Johnson KR, Miron VE, Zhao C, Quandt J, et al. (2013) Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain 136: 1035–1047.
[71]  Grimshaw MJ, Wilson JL, Balkwill FR (2002) Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol 32: 2393–2400.
[72]  Rattner A, Nathans J (2005) The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J Neurosci 25: 4540–4549.
[73]  Esser P, Heimann K, Wiedemann P (1993) Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol 77: 731–733.
[74]  Jarajapu YP, Grant MB (2010) The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res 106: 854–869.
[75]  Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118: 330–338.
[76]  Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, et al. (2009) Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 27: 670–681.
[77]  Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, et al. (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678–685.
[78]  Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076–1084.
[79]  Oh JY, Kim MK, Shin MS, Lee HJ, Ko JH, et al. (2008) The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 26: 1047–1055.
[80]  Shah K (2012) Mesenchymal stem cells engineered for cancer therapy. Adv Drug Deliv Rev 64: 739–748.
[81]  MacIsaac ZM, Shang H, Agrawal H, Yang N, Parker A, et al. (2012) Long-term in-vivo tumorigenic assessment of human culture-expanded adipose stromal/stem cells. Exp Cell Res 318: 416–423.


comments powered by Disqus